Sample for crystal structure analysis, sample precursor for crystal structure analysis, method for producing sample for crystal structure analysis, and sample preparation kit for crystal structure analysis

The use of host molecules with regular three-dimensional arrangements and crystallization-promoting molecules facilitates the inclusion and analysis of large, polar, or amphiphilic molecules, addressing the limitations of conventional crystalline sponges and streamlining the crystal structure analysis process.

WO2024248036A1PCT designated stage expired Publication Date: 2024-12-05THE UNIV OF TOKYO
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2024/019693
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-30
Filing Date
2024-05-29
Publication Date
2024-12-05

AI Technical Summary

Technical Problem

Conventional crystalline sponges are limited in their ability to include large, polar, or amphiphilic molecules due to their structural constraints, making it difficult to perform crystal structure analysis of such compounds, which often requires extensive time and effort to prepare high-quality single crystals.

Method used

A sample and method for crystal structure analysis using a single crystal with host molecules that have regular three-dimensional arrangements and internal spaces, along with crystallization-promoting molecules that facilitate affinity interactions, allowing for the inclusion and analysis of larger, polar, or amphiphilic target molecules.

Benefits of technology

Enables efficient precipitation of single crystals containing host and crystallization-promoting molecules, effectively accommodating and stabilizing target molecules, thereby simplifying and accelerating the crystal structure analysis of compounds that were previously challenging to analyze.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JP2024019693_05122024_PF_FP_ABST
    Figure JP2024019693_05122024_PF_FP_ABST
Patent Text Reader

Abstract

The present invention is: a sample precursor for crystal structure analysis, that contains a plurality of host molecules and a plurality of crystallization promoting molecules; a sample for crystal structure analysis, which is provided by the inclusion of target molecules in this sample precursor for crystal structure analysis; a method for producing the sample for crystal structure analysis; and a sample preparation kit for crystal structure analysis. The sample precursor for crystal structure analysis can perform inclusion even if the molecules of the analyte compound are, e.g., relatively large molecules, polar molecules, or amphiphilic molecules.
Need to check novelty before this filing date? Find Prior Art

Description

Sample for crystal structure analysis, precursor for sample for crystal structure analysis, method for producing sample for crystal structure analysis, and kit for producing sample for crystal structure analysis

[0001] The present invention relates to a sample for crystal structure analysis, a precursor for a sample for crystal structure analysis, a method for producing a sample for crystal structure analysis, and a kit for producing a sample for crystal structure analysis.

[0002] Single crystal structure analysis, such as single crystal X-ray diffraction, has been known as one of the highly reliable methods for determining molecular structure. However, since single crystal structure analysis requires the use of high-quality single crystals as measurement samples, it can take a lot of time and effort to prepare measurement samples when analyzing the crystal structure of unknown compounds or compounds that are difficult to crystallize.

[0003] A method for solving this problem, which utilizes a single crystal of a porous polymer compound, is known. For example, Patent Document 1 describes a method in which molecules of a compound to be analyzed are regularly arranged in the pores of a single crystal of a polymer complex, and the resulting guest molecule inclusion complex is used as a measurement sample to perform crystal structure analysis (the so-called "method for determining molecular structure by the crystalline sponge method").

[0004] WO 2014 / 038220 (US 2015 / 0219533)

[0005] By using the crystalline sponge method, crystal structure analysis can be performed even when the amount of the target compound is extremely small or when the target compound is a liquid or gas at room temperature.

[0006] However, many conventional crystalline sponges (porous polymer compounds) have the problem that they can only encapsulate small molecules and are not suitable for encapsulating polar or amphiphilic molecules.

[0007] The present invention solves this problem, and aims to provide a sample precursor for crystal structure analysis that can encapsulate molecules of a compound to be analyzed (hereinafter, "molecules of a compound to be analyzed" may be referred to as "target molecules") even if the molecules are relatively large, polar, amphiphilic, etc.; a sample for crystal structure analysis in which the target molecule is encapsulated in this sample precursor for crystal structure analysis; a method for producing this sample for crystal structure analysis; and a kit for preparing a sample for crystal structure analysis.

[0008] In order to solve the above problems, the present inventors have conducted extensive research into molecules having clathration ability. As a result, they have found that: (i) a single crystal in which host molecules having one or more openings, one or more wall portions, and an internal space surrounded by the wall portions are regularly assembled in a three-dimensional manner has spaces between the host molecules as well as the internal spaces of the host molecules as spaces that can be occupied by target molecules, and therefore can accommodate target molecules such as relatively large molecules, polar molecules, and amphiphilic molecules by utilizing both spaces; and (ii) the coexistence of host molecules and molecules having a structure that can interact with the wall portions of the host molecules in a solution facilitates the precipitation of a single crystal in which host molecules are regularly assembled in a three-dimensional manner. This has led to the completion of the present invention.

[0009] Thus, according to the present invention, there are provided the following samples for crystal structure analysis (1) to (9), a precursor for a sample for crystal structure analysis (10), a method for producing a sample for crystal structure analysis (11) to (13), and a kit for producing a sample for crystal structure analysis (14).

[0010] [1] A sample for crystal structure analysis comprising a plurality of host molecules, a plurality of crystallization-promoting molecules, and a plurality of target molecules, wherein each host molecule has one or more openings, one or more wall portions, and an internal space surrounded by the wall portions, each crystallization-promoting molecule has a structure that allows for affinity interaction with the wall portion of the host molecule, the plurality of host molecules contained in the sample for crystal structure analysis are three-dimensionally regularly assembled, each of the plurality of crystallization-promoting molecules contained in the sample for crystal structure analysis is interposed between the wall portions of two host molecules, all or a portion of the plurality of host molecules contained in the sample for crystal structure analysis accommodates the entire molecule or a portion of the molecule of the target molecule in each internal space, and the plurality of target molecules contained in the sample for crystal structure analysis are three-dimensionally regularly arranged. [2] The sample for crystal structure analysis according to [1], wherein the host molecules are polynuclear metal complexes. [3] The sample for crystal structure analysis according to [2], wherein the polynuclear metal complex contains an ion of an element selected from the group consisting of Ti, Fe, Co, Ni, Cu, Zn, Ru, Rh, Pd, Cd, Os, Ir, and Pt, and a polydentate ligand having a π-conjugated system. [4] The sample for crystal structure analysis according to [2], wherein the polydentate ligand having a π-conjugated system is represented by the following formula (1):

[0011]

[0012] (A is an m-valent group having aromaticity. X is a divalent organic group or a single bond directly connecting A and Y. Y is a coordinating atom or a monovalent group containing a coordinating atom. m is an integer of 2 to 6. Multiple Xs may be different from each other, and multiple Ys may be different from each other.) The sample for crystal structure analysis according to [3], wherein the ligand is represented by the following formula: (A is an m-valent group having aromaticity. X is a divalent organic group or a single bond directly connecting A and Y. Y is a coordinating atom or a monovalent group containing a coordinating atom. m is an integer of 2 to 6. Multiple Xs may be different from each other, and multiple Ys may be different from each other.) [5] The sample for crystal structure analysis according to any of [1] to [4], wherein the affinity interaction between the crystallization-promoting molecule and the wall portion of the host molecule is a hydrophobic interaction, a π-π interaction, or a CH-π interaction. [6] The sample for crystal structure analysis according to any of [1] to [5], wherein the crystallization-promoting molecule is a molecule having a π-conjugated system. [7] The sample for crystal structure analysis according to any of [1] to [6], wherein the crystallization-promoting molecule is a molecule having a condensed aromatic ring. [8] The sample for crystal structure analysis according to any one of [1] to [7], wherein the crystallization-promoting molecule is a molecule having an anionic group. [9] The sample for crystal structure analysis according to any one of [1] to [8], wherein the host molecule has a positive overall molecular charge and the crystallization-promoting molecule has a negative overall molecular charge, or the host molecule has a negative overall molecular charge and the crystallization-promoting molecule has a positive overall molecular charge.

[10] A sample precursor for crystal structure analysis comprising a plurality of host molecules and a plurality of crystallization-promoting molecules, wherein each host molecule has one or more openings, one or more wall portions, and an internal space surrounded by the wall portions, and each crystallization-promoting molecule has a structure that allows affinity interaction with the wall portions of the host molecule, and the plurality of host molecules contained in the sample precursor for crystal structure analysis are three-dimensionally regularly aggregated, and each of the plurality of crystallization-promoting molecules contained in the sample precursor for crystal structure analysis is interposed between the wall portions of two host molecules.

[11] A method for producing a sample for crystal structure analysis according to any one of [1] to [9], comprising a step of causing the sample precursor for crystal structure analysis according to

[10] above and a target molecule to coexist in the same system in the presence or absence of a solvent, thereby accommodating the target molecule in the internal space of all or some of the host molecules contained in the sample precursor for crystal structure analysis.

[12] A method for producing a sample for crystal structure analysis according to any one of [1] to [9], comprising the steps of: (a) causing a host molecule having one or more openings, one or more walls, and an internal space surrounded by the walls, and a target molecule to coexist in the same system in the presence or absence of a solvent, thereby accommodating the target molecule in the internal space of the host molecule (step a-I); (b) adding a crystallization-promoting molecule to a solution obtained by performing step a-I in the presence of a solvent to prepare a solution containing the host molecule accommodating the target molecule and the crystallization-promoting molecule (step a-II); or (c) dissolving the host molecule accommodating the target molecule, which is produced by performing step a-I in the absence of a solvent, and the crystallization-promoting molecule in a solvent, to prepare a solution containing the host molecule accommodating the target molecule and the crystallization-promoting molecule (step a-III); and (d) precipitating a single crystal comprising the host molecule accommodating the target molecule and the crystallization-promoting molecule from the solution obtained in step a-II or step a-III.

[13] A method for producing a sample for crystal structure analysis according to any one of [1] to [9], comprising the steps of: preparing a mixed solution by dissolving a host molecule having one or more openings, one or more wall portions, and an internal space surrounded by the wall portions, a target molecule, and a crystallization-promoting molecule in a solvent (Step b-I); and precipitating a single crystal containing the host molecule accommodating the target molecule and the crystallization-promoting molecule from the mixed solution obtained in Step b-I.

[14] A kit for producing a sample for crystal structure analysis, comprising a combination of a host molecule having one or more openings, one or more wall portions, and an internal space surrounded by the wall portions, and a crystallization-promoting molecule having a structure capable of affinity interaction with the wall portion of the host molecule.

[0013] According to the present invention, there are provided a sample for crystal structure analysis, a precursor for a sample for crystal structure analysis, a method for producing a sample for crystal structure analysis, and a kit for producing a sample for crystal structure analysis.

[0014] 2(a) is a diagram showing the positional relationship of a host molecule, a crystallization-promoting molecule, and a target molecule in a sample for crystal structure analysis obtained in Example 1. FIG. 2(a) is a diagram showing the molecular structure of a molecule constituting a sample precursor for crystal structure analysis obtained in Example 2, and an enlarged view of a portion thereof (FIG. 2(b)). FIG. 2(a) is a diagram showing the molecular structure of a molecule constituting a sample for crystal structure analysis obtained in Example 3. FIG. 2(b) is a diagram showing the molecular structure of a molecule constituting a sample for crystal structure analysis obtained in Example 4. FIG. 2(b) is a diagram showing the positional relationship of a host molecule, a crystallization-promoting molecule, and a target molecule in a sample for crystal structure analysis obtained in Example 5. FIG. 2(b) is a diagram showing the molecular structure obtained by crystal structure analysis in Example 6. FIG. 2(b) is a diagram showing the molecular structure obtained by crystal structure analysis in Example 7. FIG. 2(b) is a diagram showing the molecular structure obtained by crystal structure analysis in Example 8. FIG. 2(b) is a diagram showing the molecular structure obtained by crystal structure analysis in Example 9. FIG. 2(b) is a diagram showing the molecular structure obtained by crystal structure analysis in Example 10. FIG. 2(b) is a diagram showing the molecular structure obtained by crystal structure analysis in Example 11.

[0015] The present invention will be described in detail below, divided into the following sections: 1) a sample for crystal structure analysis, 2) a sample precursor for crystal structure analysis, 3) a method for producing a sample for crystal structure analysis, and 4) a kit for producing a sample for crystal structure analysis.

[0016] 1) Sample for crystal structure analysis The sample for crystal structure analysis of the present invention is a sample for crystal structure analysis comprising a plurality of host molecules, a plurality of crystallization-promoting molecules, and a plurality of target molecules, wherein each host molecule has one or more openings, one or more wall portions, and an internal space surrounded by the wall portions, each crystallization-promoting molecule has a structure that allows for affinity interaction with the wall portions of the host molecule, the plurality of host molecules contained in the sample for crystal structure analysis are three-dimensionally regularly assembled, the plurality of crystallization-promoting molecules contained in the sample for crystal structure analysis are each interposed between the wall portions of two host molecules, all or a portion of the plurality of host molecules contained in the sample for crystal structure analysis accommodates the entire molecule or a portion of the molecule of the target molecule in each internal space, and the plurality of target molecules contained in the sample for crystal structure analysis are three-dimensionally regularly arranged.

[0017] As used herein, the term "molecule" refers not only to electrically neutral substances composed of two or more atoms, but also to charged substances (ions) composed of two or more atoms. A "host molecule" refers to a molecule having an opening, a wall, and an internal space, and capable of accommodating a target molecule in the internal space. An "opening" refers to the portion that functions as the entrance to the internal space. A "wall" refers to the portion that separates the inside and outside of the host molecule. An "internal space" refers to a space surrounded by a wall. As long as it can accommodate a target molecule, its shape is not limited, and it may be elongated, such as a "pore." "Accommodating a target molecule in the internal space" refers to a state in which the entire target molecule is completely accommodated within the internal space, as well as a state in which a portion of the target molecule is accommodated within the internal space and the remaining portion of the target molecule protrudes from the opening. A "crystallization-promoting molecule" refers to a molecule that functions as a co-crystallization agent when added to a solution in which a host molecule is dissolved. A "target molecule" refers to a molecule of the compound to be analyzed. The expressions "a plurality of host molecules are three-dimensionally regularly assembled" and "a plurality of target molecules are three-dimensionally regularly arranged" respectively mean a state in which the molecular structure of the host molecules or the molecular structure of the target molecules can be determined by crystal structure analysis.

[0018] [Host Molecule] The host molecule contained in the sample for crystal structure analysis of the present invention is a molecule having one or more openings, one or more wall portions, and an internal space surrounded by the wall portions.

[0019] The opening functions as an entrance for the target molecule to enter the internal space. The shape and size of the opening are not particularly limited as long as the target molecule can pass through. Assuming the largest circle inscribed in the opening, its diameter is, for example, 0.1 to 5 nm, preferably 0.3 to 3 nm. The number of openings contained in the host molecule is usually 1 to 10, preferably 1 to 5.

[0020] The wall portion is a portion that functions as a wall separating the inside and outside of the host molecule, and is also a portion that can have an affinity interaction with the crystallization-promoting molecule.

[0021] The internal space is the space inside the host molecule and is the portion that accommodates the target molecule. The size of the internal space is not particularly limited as long as it can accommodate the target molecule. The internal space may be partitioned by molecular chains or the like to have a plurality of small spaces.

[0022] The charge of the entire host molecule contained in the sample for crystal structure analysis of the present invention is positive, negative, or uncharged. By optimizing the combination with the crystallization-promoting molecule, single crystals containing the host molecule can be efficiently precipitated, so the charge of the entire host molecule is preferably positive or negative. When a polynuclear metal complex, which will be described later, is used as the host molecule, the polynuclear metal complex contains a large amount of metal ions, so the host molecule will usually have a positive charge as a whole molecule.

[0023] The size of the host molecule is not particularly limited. When the smallest rectangular parallelepiped capable of accommodating the host molecule is imagined, the length of the longest side of the rectangular parallelepiped is, for example, 0.3 to 15 nm, preferably 1 to 10 nm, and the length of the shortest side is, for example, 0.3 to 15 nm, preferably 0.5 to 10 nm.

[0024] As the host molecule, a polynuclear metal complex is preferred because molecular design is relatively easy. A polynuclear metal complex is a metal complex containing two or more metal ions and a ligand. Examples of polynuclear metal complexes used as host molecules include metal complexes with a three-dimensional structure containing two or more metal ions and a ligand having two or more coordinating sites, and having an internal space. In this polynuclear metal complex, the walls of the host molecule are usually constructed by the ligands and metal ions.

[0025] The metal ion is not particularly limited as long as it can constitute a polynuclear metal complex. As the metal ion, ions of elements selected from the group consisting of Ti, Fe, Co, Ni, Cu, Zn, Ru, Rh, Pd, Cd, Os, Ir, and Pt are preferred, and ions of elements in Groups 8, 9, or 10 of the periodic table are more preferred. The valence of the metal ion is not particularly limited, and is usually 1 to 4, preferably 1 to 3, and more preferably 2.

[0026] Examples of the ligand include a ligand that constitutes the wall of the host molecule (hereinafter, sometimes referred to as "ligand (α)"), and a ligand that fulfills other roles (such as adjusting the charge of the polynuclear metal complex or occupying vacant coordination sites of metal ions to inhibit the polynuclear metal complex from polymerizing) (hereinafter, sometimes referred to as "ligand (β)").

[0027] The ligand (α) is preferably a multidentate ligand having a π-conjugated system. When the ligand (α) is a ligand having a π-conjugated system, affinity interaction with the crystallization-promoting molecule is more likely to occur. Furthermore, when the ligand (α) is a multidentate ligand, it is more likely to obtain a host molecule having an internal space suitable for accommodating the target molecule. As the multidentate ligand having a π-conjugated system, a multidentate ligand containing an aromatic group as a central skeleton is preferred. A multidentate ligand containing an aromatic group as a central skeleton is relatively rigid and has excellent planarity, so the structure of the host molecule is more likely to be maintained. Examples of the ligand (α) include those represented by the following formula (1):

[0028]

[0029] In formula (1), A is an m-valent group having aromaticity. X is a divalent organic group or a single bond directly connecting A and Y. Y is a coordinating atom or a monovalent group containing a coordinating atom. m represents an integer of 2 to 6. Multiple Xs may be different from each other, and multiple Ys may be different from each other.

[0030] The number of atoms (excluding hydrogen atoms) in the group represented by A is usually 6 to 100, preferably 6 to 60, and more preferably 6 to 30. Examples of the group represented by A include a six-membered aromatic group, a group in which a plurality of six-membered aromatic groups are linked by single bonds, and a group having a porphyrin skeleton.

[0031] Examples of the six-membered aromatic group include groups having an aromatic ring such as a benzene ring, a triazine ring, a pyridine ring, and a pyrazine ring. The six-membered aromatic group may have a substituent other than -(-X-Y). Examples of the substituent include an alkyl group having 1 to 10 carbon atoms; and a halogen atom such as a fluorine atom, a bromine atom, or a chlorine atom.

[0032] Examples of the group represented by A include, but are not limited to, the following: In addition, "*" represents a bond (position of bonding to X).

[0033]

[0034]

[0035] In the above formula, M represents a metal ion. Examples of the metal ion include the same ions as those exemplified as metal ions constituting the polynuclear metal complex. Among these, zinc ions are preferred.

[0036] The number of atoms (excluding hydrogen atoms) of the group represented by X is usually 1 to 30, preferably 2 to 20, and more preferably 2 to 10. Examples of the group represented by X include the divalent group represented by A, hydrocarbon groups such as methylene, ethylene, 1,2-ethenediyl, 1,2-ethynediyl (acetylene), p-phenylene, and m-phenylene, amide groups (-C(=O)-NH-), ester groups (-C(=O)-O-), and oxymethylene groups (-O-CH 2 -), oxyethylene group (-O-CH 2 CH 2 -), etc., but are not limited to these. The group represented by X may also be a group formed by bonding two or more of these groups. Examples of such groups include, but are not limited to, the following:

[0037]

[0038] Examples of the coordinating atom represented by Y include an oxygen atom, a sulfur atom, a nitrogen atom, and a phosphorus atom. The number of atoms (excluding hydrogen atoms) in the monovalent group represented by Y is usually 1 to 20, preferably 1 to 15, and more preferably 1 to 10. Examples of the monovalent group represented by Y include a pyridyl group, an amino group, a hydroxyl group, a deprotonated amide group, a carboxylate group, a sulfonate group, a phosphonate group, a dithiocarboxylate group, a cyano group, and groups containing these groups as a substituent. Examples of the monovalent group represented by Y include the following:

[0039]

[0040] Examples of the ligand (α) include, but are not limited to, the following:

[0041]

[0042]

[0043]

[0044] As the ligand (α), a ligand other than that represented by formula (1) can also be used. Examples of such a ligand include the following.

[0045]

[0046] The ligand (β) is preferably a ligand with a relatively low molecular weight. A low molecular weight ligand is less likely to have adverse effects, such as steric hindrance, on the coordination of the ligand (α). Examples of the ligand (β) include a monodentate ligand and a chelating ligand.

[0047] The monodentate ligand used as the ligand (β) is an oxide ion (O 2- divalent anions such as hydroxide ions (OH - ), chloride ions (Cl - ), bromide ion (Br - ), iodide ion (I - ), thiocyanate ion (SCN -) and the like; electrically neutral coordinating compounds such as water, ammonia, monoalkylamines, dialkylamines, and trialkylamines; and the like.

[0048] Examples of chelating ligands used as the ligand (β) include bidentate chelating ligands such as ethylenediamine, N,N'-dimethylethylenediamine, N,N,N',N'-tetramethylethylenediamine, 2,2'-bipyridyl, and 1,2-cyclohexanediamine, but are not limited to these.

[0049] By appropriately selecting a metal ion, a ligand (α), and a ligand (β) and using a conventionally known method, a polynuclear metal complex that can be used as a host molecule can be synthesized. Furthermore, a known polynuclear metal complex having clathration ability can be used as the host molecule. An example of such a polynuclear metal complex is shown below together with the ligand (α) that constitutes the polynuclear metal complex. When expressing the quantitative ratio of the metal ion and the ligand (α) that constitute the polynuclear metal complex, the metal ion is represented as "M," the ligand (α) as "L," and, if necessary, the second ligand (α) as "X."

[0050]

[0051] In the above formula, Pd represents a palladium ion coordinated with a bidentate chelating ligand (e.g., ethylenediamine). The main component ratio of this polynuclear metal complex is [M 6 L 4 ].

[0052]

[0053] In the above formula, Pd represents a palladium ion coordinated with a bidentate chelating ligand (e.g., ethylenediamine). The main component ratio of this polynuclear metal complex is [M 6 L 4 ].

[0054]

[0055] In the above formula, Pd represents a palladium ion coordinated with a bidentate chelating ligand (e.g., ethylenediamine). The main component ratio of this polynuclear metal complex is [M 6 L3 In the ligand represented by L, M represents a metal ion such as a Zn ion.

[0056]

[0057] In the above formula, Pd represents a palladium ion coordinated with a bidentate chelating ligand (e.g., ethylenediamine). The main component ratio of this polynuclear metal complex is [M 6 L 2 X 3 ].

[0058]

[0059] In the above formula, Pd represents a palladium ion coordinated with a bidentate chelating ligand (e.g., ethylenediamine). The main component ratio of this polynuclear metal complex is [M 6 L 1 ].

[0060]

[0061] In the above formula, Pd represents a palladium ion coordinated with a bidentate chelating ligand (e.g., ethylenediamine). The main component ratio of this polynuclear metal complex is [M 12 L 2 ].

[0062]

[0063] In the above formula, Pd represents a palladium ion coordinated with a bidentate chelating ligand (e.g., ethylenediamine). The main component ratio of this polynuclear metal complex is [M 12 L 4 ].

[0064]

[0065] In the above formula, Pd represents a palladium ion coordinated with a bidentate chelating ligand (e.g., ethylenediamine). The main component ratio of the polynuclear metal complex on the left is [M 10 L 4 ], and the main component ratio of the polynuclear metal complex on the right is [M 8 L 4 ].

[0066]

[0067] In the above formula, Pd represents a palladium ion coordinated with a bidentate chelating ligand (e.g., ethylenediamine). The main component ratio of the polynuclear metal complex on the left is [M 8 L 4 ], and the main component ratio of the polynuclear metal complex on the right is [M 6 L 4 ].

[0068]

[0069] In the above formula, Pt represents a platinum ion coordinated with a bidentate chelating ligand (e.g., ethylenediamine). The main component ratio of this polynuclear metal complex is [M 4 L 4 ].

[0070]

[0071] In the above schematic diagram, the sphere represents a palladium ion coordinated with a bidentate chelating ligand (e.g., ethylenediamine). The main component ratio of this polynuclear metal complex is [M 6 L 2 ].

[0072]

[0073] In the above schematic diagram, the sphere represents a palladium ion coordinated with a bidentate chelating ligand (e.g., ethylenediamine). The main component ratio of this polynuclear metal complex is [M 12 L 4 ].

[0074] Details of the synthesis methods of these polynuclear metal complexes are described in WO 2018 / 159692.

[0075] [Crystallization-promoting molecules] The crystallization-promoting molecules contained in the sample for crystal structure analysis of the present invention are molecules having a structure that allows for affinity interaction with the wall portion of the host molecule. Because the crystallization-promoting molecules have such a structure, adding the crystallization-promoting molecules to a solution in which the host molecules are dissolved can efficiently precipitate single crystals containing the host molecules and the crystallization-promoting molecules.

[0076] Examples of the affinity interaction between the crystallization-promoting molecule and the wall portion of the host molecule include hydrophobic interaction, π-π interaction, CH-π interaction, etc. Among these, π-π interaction is preferred as the affinity interaction between the crystallization-promoting molecule and the wall portion of the host molecule because it is a larger interaction.

[0077] The crystallization-promoting molecule is preferably a molecule having a π-conjugated system, which is likely to form π-π interactions or CH-π interactions with the wall of the host molecule.

[0078] The crystallization-promoting molecule is preferably a molecule having a condensed aromatic ring, which tends to have excellent planarity and is therefore suitable for being interposed between the walls of two host molecules.

[0079] The crystallization-promoting molecule is preferably a molecule having an anionic group. When the host molecule is a polynuclear metal complex, the host molecule tends to have a positive charge as a whole. In this case, the crystallization-promoting molecule having an anionic group and having a negative charge as a whole molecule can function as a counter ion.

[0080] Examples of the anionic group include a carboxylate ion group, a sulfonate ion group, and a phosphate ion group, with the carboxylate ion group and sulfonate ion group being preferred.

[0081] Examples of the crystallization-promoting molecule include a molecule having a pyrene skeleton, a molecule having a naphthalene skeleton, a molecule having a benzene skeleton, and a molecule having a biphenyl skeleton.

[0082] Examples of the crystallization-promoting molecule having a pyrene skeleton include molecules represented by the following formula:

[0083]

[0084] Examples of crystallization-promoting molecules having a naphthalene skeleton include molecules represented by the following formula:

[0085]

[0086] Examples of crystallization-promoting molecules having a benzene skeleton include molecules represented by the following formula:

[0087]

[0088] Examples of the crystallization-promoting molecule having a biphenyl skeleton include molecules represented by the following formula:

[0089]

[0090] The crystallization-promoting molecule to be used is preferably selected taking into consideration the size and shape of the wall of the host molecule. For example, when the multidentate ligand constituting the wall is 2,4,6-tris(4-pyridyl)-1,3,5-triazine, the crystallization-promoting molecule is preferably a molecule having a pyrene skeleton or a naphthalene skeleton, since it easily interacts with molecules having aromatic planes of the same size and similar shape. Similarly, when the multidentate ligand constituting the wall is 2,4,6-tris(3-pyridyl)-1,3,5-triazine, a molecule having a naphthalene skeleton is preferred.

[0091] [Target Molecule] The target molecule contained in the sample for crystal structure analysis of the present invention is a molecule of a compound to be structurally analyzed. The form of the target molecule is not particularly limited, and it may be in a solid, liquid, or gaseous state at room temperature (20°C).

[0092] In the crystal structure analysis sample of the present invention, the target molecule can occupy not only the internal space of the host molecule but also the space between the host molecules. The internal space of the host molecule tends to be hydrophobic, while the space between the host molecules tends to be hydrophilic. Therefore, molecules that were not suitable as target molecules in the conventional crystalline sponge method (e.g., relatively large molecules, polar molecules, amphiphilic molecules, etc.) are also suitable as target molecules constituting the crystal structure analysis sample of the present invention.

[0093] The molecular weight of the target molecule is usually 2,000 or less, preferably 800 or less. There is no particular lower limit to the molecular weight of the target molecule, but it is usually 50 or more.

[0094] [Sample for crystal structure analysis] In the sample for crystal structure analysis of the present invention, a plurality of host molecules are assembled in a three-dimensionally regular pattern. All or some of these host molecules accommodate the entire or a part of the target molecule in their respective internal spaces. Furthermore, the target molecules accommodated in the internal spaces of the host molecules are arranged in a three-dimensionally regular pattern. Therefore, by performing crystal structure analysis using the sample for crystal structure analysis of the present invention, the molecular structure of the target molecule can be clarified.

[0095] In the sample for crystal structure analysis of the present invention, each of the plurality of crystallization-promoting molecules is interposed between the wall portions of the two host molecules. The crystallization-promoting molecules interposed between the wall portions of the two host molecules contribute to stabilization of the sample for crystal structure analysis.

[0096] In the crystal structure analysis sample of the present invention, the host molecule and the crystallization-promoting molecule preferably have different charges. Specifically, the host molecule may have a positive overall charge and the crystallization-promoting molecule may have a negative overall charge, or the host molecule may have a negative overall charge and the crystallization-promoting molecule may have a positive overall charge. When the host molecule and the crystallization-promoting molecule have different charges, the crystallization-promoting molecule functions as a counter ion of the host molecule, allowing for efficient production of a crystal structure analysis sample. Furthermore, crystal structure analysis samples in which the host molecule and the crystallization-promoting molecule have different charges are highly stable. Furthermore, single crystals containing host molecules and crystallization-promoting molecules with different charges are often precipitated from aqueous solutions, and the space between the host molecules in the single crystal tends to be hydrophilic. Therefore, in crystal structure analysis samples in which the host molecule and the crystallization-promoting molecule have different charges, target molecules such as polar molecules and amphiphilic molecules tend to be stably accommodated.

[0097] The size of the sample for crystal structure analysis is not particularly limited. When clarifying the molecular structure of a target molecule, it is preferable to use a sample for crystal structure analysis of a size suitable for the crystal structure analyzer to be used. For example, when performing crystal structure analysis using a commercially available X-ray crystal structure analyzer, when the smallest rectangular parallelepiped capable of accommodating the sample for crystal structure analysis is imagined, the length of its long side is usually 10 to 500 μm, preferably 50 to 500 μm, and the length of its short side is usually 10 to 500 μm, preferably 10 to 200 μm.

[0098] When a plurality of samples for crystal structure analysis are irradiated with synchrotron X-rays and the molecular structure of a target compound is determined based on the collected diffraction intensity data, the minimum rectangular parallelepiped that can accommodate the samples for crystal structure analysis is imagined to have a long side length of usually 0.1 to 100 μm, preferably 1 to 100 μm, and a short side length of usually 0.1 to 100 μm, preferably 1 to 10 μm.

[0099] When crystal structure analysis is performed by microelectron diffraction, when the smallest rectangular parallelepiped capable of accommodating a sample for crystal structure analysis is imagined, the length of its long side is usually 0.1 to 1000 nm, preferably 1 to 1000 nm, and the length of its short side is usually 0.1 to 100 nm, preferably 0.1 to 10 nm.

[0100] 2) Sample precursor for crystal structure analysis The sample precursor for crystal structure analysis of the present invention is a sample precursor for crystal structure analysis comprising a plurality of host molecules and a plurality of crystallization-promoting molecules, wherein each host molecule has one or more openings, one or more wall portions, and an internal space surrounded by the wall portions, and each crystallization-promoting molecule has a structure that enables affinity interaction with the wall portion of the host molecule, and the plurality of host molecules contained in the sample precursor for crystal structure analysis are three-dimensionally regularly assembled, and the plurality of crystallization-promoting molecules contained in the sample precursor for crystal structure analysis are each interposed between the wall portions of two host molecules.

[0101] The sample precursor for crystal structure analysis of the present invention is similar to the sample for crystal structure analysis of the present invention, except that the target molecule is not accommodated in the internal space of the host molecule.

[0102] The method for producing the precursor of the sample for crystal structure analysis of the present invention is not particularly limited. For example, the precursor of the sample for crystal structure analysis of the present invention can be obtained by preparing a solution containing a host molecule and a crystallization-promoting molecule, and allowing the solution to stand to precipitate as a single crystal.

[0103] The concentration of the host molecule in the solution containing the host molecule and the crystallization-promoting molecule is usually 0.1 to 50 mM, preferably 5 to 20 mM. The amount of the crystallization-promoting molecule in the solution containing the host molecule and the crystallization-promoting molecule is usually 0.1 to 10 equivalents, preferably 0.1 to 4 equivalents, relative to the host molecule. The temperature of the solution when precipitating the single crystal is usually 0 to 80°C, preferably 4 to 50°C. The standing time when precipitating the single crystal is usually 1 to 240 hours, preferably 1 to 24 hours.

[0104] 3) Method for Producing a Sample for Crystal Structure Analysis The method for producing a sample for crystal structure analysis of the present invention is not particularly limited. For example, the sample for crystal structure analysis of the present invention can be produced by the following production method (A), production method (B), or production method (C).

[0105] [Production Method (A)] Production method (A) includes a step of causing the sample precursor for crystal structure analysis and a target molecule to coexist in the same system in the presence or absence of a solvent, thereby accommodating the target molecule in the internal space of all or some of the host molecules contained in the sample precursor for crystal structure analysis.

[0106] "The coexistence of a crystal structure analysis sample precursor and a target molecule in the same system" means that these components are placed in a state where they can come into contact with each other. Therefore, the "same system" does not have to be a single-phase system as a whole.

[0107] An example of a state in which a sample precursor for crystal structure analysis and a target molecule coexist in the same system in the presence of a solvent is a state in which the sample precursor for crystal structure analysis is immersed in a solution or suspension produced by dissolving at least a portion of the target molecule in a solvent. In this case, it is important that the immersed sample precursor for crystal structure analysis does not dissolve in the solvent. For example, the sample for crystal structure analysis of the present invention can be produced by using a solvent in which the sample precursor for crystal structure analysis does not dissolve, or by contacting the sample precursor for crystal structure analysis with the target molecule using the mother liquor produced when the sample precursor for crystal structure analysis is produced.

[0108] Examples of a state in which a sample precursor for crystal structure analysis and a target molecule coexist in the same system in the absence of a solvent include a state in which the sample precursor for crystal structure analysis is placed in a container in which gaseous target molecules are present, and a state in which the sample precursor for crystal structure analysis is immersed in liquid target molecules.

[0109] After the target molecules come into contact with the sample precursor for crystal structure analysis, the target molecules are accommodated in the internal space of the host molecule that constitutes the sample precursor for crystal structure analysis. At this time, if each target molecule is accommodated in a more stable state, the multiple target molecules will be regularly arranged as a whole.

[0110] The amount of the target molecule that is allowed to coexist with the crystal structure analysis sample precursor is usually 0.1 mol or more, preferably 0.5 mol or more, per mol of the host molecule.

[0111] The conditions for accommodating the target molecule in the internal space of the host molecule constituting the crystal structure analysis sample precursor are not particularly limited. The temperature for accommodating the target molecule in the internal space of the host molecule is usually 0 to 100°C, preferably 20 to 100°C. The time for accommodating the target molecule in the internal space of the host molecule is usually 30 seconds to 72 hours, preferably 0.5 to 24 hours.

[0112] [Production Method (B)] Production method (B) comprises the following steps: a step of causing a host molecule having one or more openings, one or more wall portions, and an internal space surrounded by the wall portions, and a target molecule to coexist in the same system in the presence or absence of a solvent, thereby accommodating the target molecule in the internal space of the host molecule (Step a-I); a step of adding a crystallization-promoting molecule to a solution obtained by performing Step a-I in the presence of a solvent, thereby preparing a solution containing the host molecule accommodating the target molecule and the crystallization-promoting molecule (Step a-II); or a step of dissolving the host molecule accommodating the target molecule, which has been produced by performing Step a-I in the absence of a solvent, and the crystallization-promoting molecule, in a solvent, thereby preparing a solution containing the host molecule accommodating the target molecule and the crystallization-promoting molecule (Step a-III); and a step of precipitating a single crystal comprising the host molecule accommodating the target molecule and the crystallization-promoting molecule from the solution obtained in Step a-II or Step a-III.

[0113] Step a-I is a step in which a host molecule and a target molecule are allowed to coexist in the same system in the presence or absence of a solvent, thereby accommodating the target molecule in the internal space of the host molecule. Step a-I can be performed in the same manner as production method (A), except that a host molecule is used instead of the crystal structure analysis sample precursor in production method (A). However, when the host molecule and the target molecule are allowed to coexist in the same system in the presence of a solvent, it is preferable that the host molecule is dissolved in the solvent. Dissolving the host molecule in the solvent allows for more efficient production of a host molecule accommodating the target molecule. In step a-I, it is possible to confirm that the target molecule has been incorporated into the internal space of the host molecule by observing a color change or measuring an NMR spectrum.

[0114] The amount of the target molecule that is allowed to coexist with the host molecule is usually 0.1 equivalent or more, preferably 1 equivalent or more, relative to the host molecule.

[0115] Step a-II and step a-III are both steps for preparing a solution containing host molecules accommodating target molecules and crystallization-promoting molecules. When step a-I is performed in the presence of a solvent, the target solution can be prepared by step a-II. If the target molecules and host molecules remain undissolved and form a suspension at the time step a-I is completed, it is preferable to perform step a-II on the filtrate obtained by filtration. When step a-I is performed in the absence of a solvent, the target solution can be prepared by step a-III.

[0116] The concentration of the host molecule accommodating the target molecule in the solution prepared in step a-II or step a-III is usually 0.1 to 50 mM, preferably 1 to 20 mM. The amount of the crystallization-promoting molecule in the solution prepared in step a-II or step a-III is usually 0.1 to 10 equivalents, preferably 0.1 to 1 equivalent, relative to the host molecule.

[0117] Step a-IV is a step of precipitating a single crystal containing a host molecule accommodating a target molecule and a crystallization-promoting molecule from the solution obtained in Step a-II or Step a-III. The temperature of the solution during precipitating the single crystal is usually 0 to 80°C, preferably 4 to 50°C. The standing time during precipitating the single crystal is usually 1 to 240 hours, preferably 1 to 24 hours.

[0118] [Production Method (C)] Production method (C) is a method for producing a sample for crystal structure analysis, comprising: a step (step b-I) of preparing a mixed solution by dissolving a host molecule having one or more openings, one or more wall portions, and an internal space surrounded by the wall portions, a target molecule, and a crystallization-promoting molecule in a solvent; and a step (step b-II) of precipitating a single crystal containing the host molecule accommodating the target molecule and the crystallization-promoting molecule from the mixed solution obtained in step b-I.

[0119] Step b-I is a step of preparing a mixed solution by dissolving a host molecule, a target molecule, and a crystallization-promoting molecule in a solvent. The concentration of the host molecule in the mixed solution is usually 0.1 to 50 mM, preferably 1 to 20 mM. The amount of the crystallization-promoting molecule in the mixed solution is usually 0.1 to 10 equivalents, preferably 0.1 to 4 equivalents, relative to the host molecule. The amount of the target molecule in the mixed solution is usually 0.1 equivalents or more, preferably 1 equivalent or more, relative to the host molecule.

[0120] Step b-II is a step of precipitating a single crystal containing a host molecule accommodating a target molecule and a crystallization-promoting molecule from the mixed solution obtained in Step b-I. The temperature of the solution when precipitating the single crystal is usually 0 to 80° C., preferably 4 to 50° C. The standing time when precipitating the single crystal is usually 1 to 240 hours, preferably 1 to 24 hours.

[0121] Examples of the solvent used in Production Methods (A) to (C) include aromatic hydrocarbons such as benzene, toluene, xylene, chlorobenzene, 1,2-dichlorobenzene, and nitrobenzene; aliphatic hydrocarbons such as n-pentane, n-hexane, and n-heptane; alicyclic hydrocarbons such as cyclopentane, cyclohexane, and cycloheptane; nitriles such as acetonitrile and benzonitrile; sulfoxides such as dimethyl sulfoxide (DMSO); amides such as N,N-dimethylformamide and n-methylpyrrolidone; ethers such as diethyl ether, tetrahydrofuran, 1,2-dimethoxyethane, and 1,4-dioxane; alcohols such as methanol, ethanol, and isopropyl alcohol; ketones such as acetone, methyl ethyl ketone, and cyclohexanone; cellosolves such as ethyl cellosolve; halogenated hydrocarbons such as dichloromethane, chloroform, carbon tetrachloride, and 1,2-dichloroethane; esters such as methyl acetate, ethyl acetate, ethyl lactate, and ethyl propionate; and water. These solvents may be used alone or in combination of two or more.

[0122] 4) Sample Preparation Kit for Crystal Structure Analysis The sample preparation kit for crystal structure analysis of the present invention comprises a combination of a host molecule having one or more openings, one or more wall portions, and an internal space surrounded by the wall portions, and a crystallization-promoting molecule having a structure that allows for an affinity interaction with the wall portion of the host molecule.

[0123] The "host molecule" and "crystallization-promoting molecule" constituting the crystal structure analysis sample preparation kit of the present invention are the same as those described in the "crystal structure analysis sample" invention. The "host molecule" and "crystallization-promoting molecule" constituting the crystal structure analysis sample preparation kit of the present invention may each be in the form of a pure substance or in the form of a solution. The crystal structure analysis sample preparation kit of the present invention may contain two or more types of host molecules and / or two or more types of crystallization-promoting molecules.

[0124] By using the crystal structure analysis sample preparation kit of the present invention, the crystal structure analysis sample precursor of the present invention can be efficiently produced. By using the crystal structure analysis sample preparation kit of the present invention, the crystal structure analysis sample of the present invention can be efficiently produced by the production method (B) or the production method (C).

[0125] The present invention will be described in more detail below with reference to examples, although the present invention is not limited to the following examples in any way.

[0126] Synthesis Example 1 [{(N,N,N',N'-tetramethylethylenediamine)palladium} 6 (2,4,6-tris(4-pyridyl)-1,3,5-triazine) 4 ] Synthesis of Nitrate) A nitrate of the octahedral metal complex shown below (hereinafter, sometimes referred to as "host molecule 1") was synthesized according to the method described in J. Am. Chem. Soc. 2004, 126, 9172-9173.

[0127]

[0128] Synthesis Example 2 [{(N,N,N',N'-tetramethylethylenediamine)platinum} 6(2,4,6-tris(3-pyridyl)-1,3,5-triazine) 4 Synthesis of nitrate) 416 mg of 2,4,6-tris(3-pyridyl)-1,3,5-triazine, 869 mg of (N,N,N',N'-tetramethylethylenediamine)platinum nitrato complex, and 215 mg of pyrene were suspended in 16 mL of water and heated with stirring at 100°C for one week. The resulting aqueous solution was washed with dichloromethane and then freeze-dried to synthesize 969 mg of the nitrate of the bowl-shaped metal complex shown below (hereinafter, sometimes referred to as "host molecule 2"). Note that the pyrene used in Synthesis Example 2 is a template molecule for synthesizing host molecule 2 and is removed from the reaction system by washing with dichloromethane. Therefore, the powder of nitrate of host molecule 2 obtained in Synthesis Example 2 does not contain pyrene.

[0129]

[0130] [Single-crystal X-ray crystal structure analysis] Single-crystal X-ray crystal structure analysis was carried out using a Synergy-S diffractometer (Cu-Kα ray (wavelength 1.5418 Å)) manufactured by Rigaku Corporation.

[0131] Example 1 Digoxin powder was added in an amount of 5 equivalents relative to the host molecule 1 to an aqueous solution of the nitrate salt of host molecule 1 (10 mM, 200 μL) to obtain a suspension. The resulting suspension was stirred at 60°C for 15 minutes and then filtered using a syringe filter. To the filtrate was added an aqueous solution of 1,3,6,8-pyrenetetrasulfonic acid tetrasodium salt (20 mM, 10 μL, 0.1 equivalent relative to the host molecule 1), and the mixture was allowed to stand at 5°C for 12 hours to precipitate crystals. Crystal structure analysis was performed using the precipitated crystals (long side length: approximately 200 μm). Figure 1 shows the molecular structure obtained by crystal structure analysis. As shown in Figure 1, the non-sugar moiety of digoxin is accommodated in the internal space of host molecule 1, while the sugar moiety of digoxin protrudes from the internal space of the host molecule and occupies the space between adjacent host molecules 1. Furthermore, the skeleton portion of the 1,3,6,8-pyrenetetrasulfonate ion is in a state that is almost parallel to the wall portion of the host molecule 1, and the 1,3,6,8-pyrenetetrasulfonate ion interacts with the wall portion of the host molecule 1 through affinity.

[0132]

[0133] Example 2 An aqueous solution of 1,3,6,8-pyrenetetrasulfonic acid tetrasodium salt (20 mM, 40 μL, 0.2 equivalents relative to host molecule 1) was added to an aqueous solution of the nitrate salt of host molecule 1 (20 mM, 200 mL), and the mixture was allowed to stand at 20°C for 10 hours to precipitate crystals. Crystal structure analysis was performed using the precipitated crystals (long side length: approximately 200 μm). Figure 2(a) shows the molecular structure obtained by crystal structure analysis. An enlarged view of a portion of the structure is shown in Figure 2(b). As shown in Figure 2, 1,3,6,8-pyrenetetrasulfonic acid ions are interposed between the walls of two host molecules 1. Note that the sulfonate ion groups of the 1,3,6,8-pyrenetetrasulfonic acid ions are omitted in Figure 2(b).

[0134] Example 3 Crystals were synthesized using the same method as in Example 2. Approximately 50 crystals were extracted from the crystals along with 10 μL of mother liquor. 0.1 mg of n-octyl-β-D-1-thioglucopyranoside was added to the mother liquor in which the crystals were immersed, and the mixture was allowed to stand at 20°C for 12 hours. The immersed crystals were then extracted and subjected to crystal structure analysis. Figure 3 shows the molecular structure obtained by crystal structure analysis. Note that the sulfonate ion group of the 1,3,6,8-pyrenetetrasulfonate ion is omitted in Figure 3.

[0135]

[0136] Example 4 Crystals were synthesized in the same manner as in Example 2. Approximately 50 crystals were extracted from the crystals along with 10 μL of mother liquor. 0.1 mg of N-(tert-butoxycarbonyl)-L-tryptophan was added to the mother liquor in which the crystals were immersed, and the mixture was allowed to stand at 20°C for 12 hours. The immersed crystals were then extracted and subjected to crystal structure analysis. Figure 4 shows the molecular structure obtained by crystal structure analysis. Note that the sulfonate ion group of the 1,3,6,8-pyrenetetrasulfonate ion is omitted in Figure 4.

[0137]

[0138] Example 5 A suspension was obtained by adding 5 equivalents of pyrene powder relative to the host molecule 2 to an aqueous solution of the nitrate salt of the host molecule 2 (10 mM, 1 mL). The resulting suspension was stirred at 100°C for 10 minutes and then filtered using a syringe filter. To the filtrate was added an aqueous solution of 1,5-naphthalenedisulfonic acid disodium salt (20 mM, 1.5 mL, 3 equivalents relative to the host molecule 2), and the mixture was allowed to stand at 25°C for 24 hours to precipitate crystals. Crystal structure analysis was performed using the precipitated crystals (long side length approximately 200 μm). Figure 5 shows the molecular structure obtained by crystal structure analysis. As shown in Figure 5, two pyrene molecules are accommodated in the internal space of the host molecule 2. Furthermore, the backbone portion of the 1,5-naphthalenedisulfonic acid ion is approximately parallel to the wall of the host molecule 2, and the 1,5-naphthalenedisulfonic acid ion interacts with the wall of the host molecule 2 through affinity.

[0139] Example 6 Crystals were synthesized using the same method as in Example 2. One crystal was extracted from the mixture along with 20 μL of mother liquor. 10 μg of methylandrostenediol was added to the mother liquor containing the crystal, and the mixture was allowed to stand at 20° C. for 12 hours. The immersed crystal was then extracted and subjected to crystal structure analysis. Figure 6 shows the molecular structure obtained by crystal structure analysis.

[0140]

[0141] Example 7 A suspension was prepared by adding 1 mg of methylandrostenediol powder to an aqueous solution of the nitrate salt of host molecule 1 (20 mM, 200 μL). The resulting suspension was stirred at 60°C for 15 minutes and then filtered using a syringe filter. The filtrate (100 μL) was transferred to a round-bottom glass tube with an inner diameter of 6 mm and a length of 40 mm. An aqueous solution of 1,3,6,8-pyrenetetrasulfonic acid tetrasodium salt (20 mM, 20 μL, 0.2 equivalents relative to host molecule 1) and an aqueous agarose solution (0.5% w / w, 100 μL) were added, mixed at 60°C, and then allowed to stand at 20°C for 1 hour. A mixture of an aqueous agarose solution (0.5% w / w, 100 μL) and an aqueous sodium tetrafluoroborate solution (200 mM, 20 μL) was added to the mixture and allowed to stand for 12 hours to precipitate crystals. Of the dozens of precipitated crystals, several were sucked up along with the gel using a glass pipette and placed on a glass plate, after which the crystals were mixed with protective oil (Paraton). Visually inspecting under a stereomicroscope, one crystal without cracks was selected, placed in a single crystal diffractometer loop, and placed in the diffractometer to obtain an X-ray diffraction image. Crystal structure analysis was performed based on this image. Figure 7 shows the molecular structure obtained through crystal structure analysis.

[0142] Example 8 A suspension was obtained by adding 4.9 mg (1 equivalent relative to host molecule 1) of glycocholate sodium salt powder to an aqueous solution of the nitrate salt of host molecule 1 (20 mM, 500 μL). The resulting suspension was stirred at 60°C for 15 minutes and then filtered using a syringe filter. The filtrate (25 μL) was transferred to a round-bottom glass tube with an inner diameter of 6 mm and a length of 40 mm. An aqueous solution of 1,3,6,8-pyrenetetrasulfonic acid tetrasodium salt (20 mM, 5 μL, 0.2 equivalent relative to host molecule 1) and an aqueous agarose solution (0.5% w / w, 50 μL) were added, mixed at 60°C, and then allowed to stand at 20°C for 1 hour. A mixture of aqueous agarose solution (0.5% w / w, 100 μL) and aqueous sodium tetrafluoroborate solution (400 mM, 40 μL) was heated to 60°C and added to the mixture. The mixture was then allowed to stand for 12 hours to precipitate crystals. Several of the dozens of precipitated crystals were sucked up along with the gel using a glass pipette and placed on a glass plate. The crystals were then mixed with protective oil (Paraton). Visually inspecting the crystal under a stereomicroscope, a single crack-free crystal was selected, placed in a single crystal diffractometer loop, and placed in the diffractometer to obtain an X-ray diffraction image. Crystal structure analysis was performed based on this image. Figure 8 shows the molecular structure obtained by crystal structure analysis.

[0143]

[0144] Example 9 A suspension was obtained by adding 5.2 mg (1 equivalent relative to host molecule 1) of beclomethasone propionate powder to an aqueous solution of the nitrate salt of host molecule 1 (20 mM, 500 μL). The resulting suspension was stirred at 60°C for 15 minutes and then filtered using a syringe filter. The filtrate (25 μL) was transferred to a round-bottom glass tube with an inner diameter of 6 mm and a length of 40 mm. An aqueous solution of 1,3,6,8-pyrenetetrasulfonic acid tetrasodium salt (20 mM, 5 μL, 0.2 equivalent relative to host molecule 1) and an aqueous agarose solution (0.5% w / w, 50 μL) were added, mixed at 60°C, and then allowed to stand at 20°C for 1 hour. A mixture of aqueous agarose solution (0.5% w / w, 100 μL) and aqueous sodium tetrafluoroborate solution (400 mM, 40 μL) was heated to 60°C and added to the mixture. The mixture was then allowed to stand for 12 hours to precipitate crystals. Several of the dozens of precipitated crystals were sucked up along with the gel using a glass pipette and placed on a glass plate. The crystals were then mixed with protective oil (Paraton). Visually inspecting the crystal under a stereomicroscope, a single crack-free crystal was selected, placed in a single crystal diffractometer loop, and placed in the diffractometer to obtain an X-ray diffraction image. Crystal structure analysis was performed based on this image. Figure 9 shows the molecular structure obtained by crystal structure analysis.

[0145]

[0146] Example 10: A suspension was obtained by adding 12.3 mg (1 equivalent relative to host molecule 1) of digitonin powder to an aqueous solution of the nitrate salt of host molecule 1 (20 mM, 500 μL). The resulting suspension was stirred at 60°C for 15 minutes and then filtered using a syringe filter. The filtrate (100 μL) was transferred to a round-bottom glass tube with an inner diameter of 6 mm and a length of 40 mm. An aqueous solution of 1,3,6,8-pyrenetetrasulfonic acid tetrasodium salt (20 mM, 20 μL, 0.2 equivalent relative to host molecule 1) and an aqueous agarose solution (0.5% w / w, 100 μL) were added, mixed at 60°C, and then allowed to stand at 20°C for 1 hour. A mixture of aqueous agarose solution (0.25% w / w, 200 μL) and aqueous sodium tetrafluoroborate solution (400 mM, 40 μL) was heated to 60°C and added to the mixture. The mixture was then allowed to stand for 12 hours to precipitate crystals. Several of the dozens of precipitated crystals were sucked up along with the gel using a glass pipette and placed on a glass plate. The crystals were then mixed with protective oil (Paraton). Visually inspecting the crystal under a stereomicroscope, a single crack-free crystal was selected, placed in a single crystal diffractometer loop, and placed in the diffractometer to obtain an X-ray diffraction image. Crystal structure analysis was performed based on this image. Figure 10 shows the molecular structure obtained by crystal structure analysis.

[0147]

[0148] Example 11 A suspension was obtained by adding 6.9 mg (1 equivalent relative to host molecule 1) of monensin sodium salt powder to an aqueous solution of the nitrate salt of host molecule 1 (20 mM, 500 μL). The resulting suspension was stirred at 60°C for 15 minutes and then filtered using a syringe filter. The filtrate (10 μL) was transferred to a glass capillary tube with an inner diameter of 1 mm, and an aqueous solution of 1,3,6,8-pyrenetetrasulfonic acid tetrasodium salt (20 mM, 2 μL, 0.2 equivalent relative to host molecule 1) and an aqueous agarose solution (0.5% w / w, 10 μL) were added. The mixture was mixed at 60°C and then allowed to stand at 20°C for 1 hour. A mixture of aqueous agarose solution (0.25% w / w, 20 μL) and aqueous sodium hexafluoroantimonate solution (100 mM, 2 μL) was heated to 60°C and added to this mixture. The mixture was then allowed to stand for 12 hours to precipitate crystals. Several of the dozens of precipitated crystals were sucked up along with the gel using a glass pipette and placed on a glass plate, after which the crystals were mixed with protective oil (Paraton). Visually inspecting the crystal under a stereomicroscope, a single crack-free crystal was selected, placed in a single crystal diffractometer loop, and placed in the diffractometer to obtain an X-ray diffraction image. Crystal structure analysis was performed based on this image. Figure 11 shows the molecular structure obtained by crystal structure analysis.

[0149]

Claims

1. A sample for crystal structure analysis comprising a plurality of host molecules, a plurality of crystallization-promoting molecules, and a plurality of target molecules, wherein each host molecule has one or more openings, one or more walls, and an internal space surrounded by the walls, each crystallization-promoting molecule has a structure capable of affinity interaction with the wall of the host molecule, the plurality of host molecules contained in the sample for crystal structure analysis are three-dimensionally regularly assembled, each of the plurality of crystallization-promoting molecules contained in the sample for crystal structure analysis is interposed between the walls of two host molecules, all or a portion of the plurality of host molecules contained in the sample for crystal structure analysis accommodates the entire molecule or a portion of the molecule of the target molecule in each internal space, and the plurality of target molecules contained in the sample for crystal structure analysis are three-dimensionally regularly arranged.

2. The sample for crystal structure analysis according to claim 1, wherein the host molecule is a polynuclear metal complex.

3. The sample for crystal structure analysis according to claim 2, wherein the polynuclear metal complex contains an ion of an element selected from the group consisting of Ti, Fe, Co, Ni, Cu, Zn, Ru, Rh, Pd, Cd, Os, Ir, and Pt, and a multidentate ligand having a π-conjugated system.

4. The polydentate ligand having a π-conjugated system is represented by the following formula (1): (A is an m-valent group having aromaticity. X is a divalent organic group, or a single bond directly connecting A and Y. Y is a coordinating atom, or a monovalent group containing a coordinating atom. m is an integer of 2 to 6. A plurality of Xs may be different from each other, and a plurality of Ys may be different from each other.) 5. The sample for crystal structure analysis according to claim 1, wherein the affinity interaction between the crystallization-promoting molecule and the wall portion of the host molecule is a hydrophobic interaction, a π-π interaction, or a CH-π interaction.

6. The sample for crystal structure analysis according to claim 1, wherein the crystallization-promoting molecule is a molecule having a π-conjugated system.

7. The sample for crystal structure analysis according to claim 1, wherein the crystallization-promoting molecule is a molecule having a condensed aromatic ring.

8. The sample for crystal structure analysis according to claim 1, wherein the crystallization-promoting molecule is a molecule having an anionic group.

9. A sample for crystal structure analysis as described in claim 1, wherein the host molecule has a positive charge overall and the crystallization-promoting molecule has a negative charge overall, or the host molecule has a negative charge overall and the crystallization-promoting molecule has a positive charge overall.

10. A sample precursor for crystal structure analysis comprising a plurality of host molecules and a plurality of crystallization-promoting molecules, wherein each host molecule has one or more openings, one or more wall portions, and an internal space surrounded by the wall portions, each crystallization-promoting molecule has a structure capable of affinity interaction with the wall portions of the host molecules, the plurality of host molecules contained in the sample precursor for crystal structure analysis are regularly assembled in three dimensions, and the plurality of crystallization-promoting molecules contained in the sample precursor for crystal structure analysis are each interposed between the wall portions of two host molecules.

11. A method for producing a sample for crystal structure analysis as described in claim 1, comprising a step of causing the sample precursor for crystal structure analysis as described in claim 10 and a target molecule to coexist in the same system in the presence or absence of a solvent, thereby accommodating the target molecule in the internal space of all or a part of the host molecule contained in the sample precursor for crystal structure analysis.

12. A method for producing a sample for crystal structure analysis according to claim 1, comprising: a step of accommodating the target molecule in the internal space of the host molecule by allowing a host molecule having one or more openings, one or more walls, and an internal space surrounded by the walls to coexist with a target molecule in the same system in the presence or absence of a solvent (step a-I); a step of preparing a solution containing the host molecule accommodating the target molecule and the crystallization-promoting molecule by adding a crystallization-promoting molecule to a solution obtained by carrying out step a-I in the presence of a solvent (step a-II), or a step of preparing a solution containing the host molecule accommodating the target molecule and the crystallization-promoting molecule by dissolving the host molecule accommodating the target molecule and the crystallization-promoting molecule produced by carrying out step a-I in the absence of a solvent in a solvent (step a-III); and a step of precipitating a single crystal containing the host molecule accommodating the target molecule and the crystallization-promoting molecule from the solution obtained in step a-II or step a-III (step a-IV).

13. A method for producing a sample for crystal structure analysis as described in claim 1, comprising: a step (step b-I) of preparing a mixed solution by dissolving a host molecule having one or more openings, one or more walls, and an internal space surrounded by the walls, a target molecule, and a crystallization-promoting molecule in a solvent; and a step (step b-II) of precipitating a single crystal containing the host molecule accommodating the target molecule and the crystallization-promoting molecule from the mixed solution obtained in step b-I.

14. A sample preparation kit for crystal structure analysis comprising a combination of a host molecule having one or more openings, one or more walls, and an internal space surrounded by the walls, and a crystallization-promoting molecule having a structure capable of affinity interaction with the walls of the host molecule.

Citation Information

Patent Citations

  • Guest-compound-enveloping polymer-metal-complex crystal, method for producing same, method for preparing crystal structure analysis sample, and method for determining molecular structure of organic compound

    US20150219533A1

  • Guest-compound-enveloping polymer-metal-complex crystal, method for producing same, method for preparing crystal structure analysis sample, and method for determining molecular structure of organic compound

    WO2014038220A1

  • Porous polymer compound, separation method of compound to be separated, single crystal, fabrication method of sample for crystal structure analysis, and molecular structure determination method of compound to be analyzed

    JP2016160256A

  • Method for preparing sample for crystalline structure analysis, for structure analysis of hydrophilic organic compound having polar group by crystalline sponge method

    JP2019172593A

  • Method of preparing crystal structure analysis samples for structural analysis of compounds with nucleophilic groups by crystalline sponge method

    JP2021081369A